MétaCan
Menu
← Back to cohort
Record W2765185165 · doi:10.5489/cuaj.5007

The emerging role of patient reported outcomes in urology

2017· article· en· W2765185165 on OpenAlexaffvenueabout
Jason Izard

Bibliographic record

VenueCanadian Urological Association Journal · 2017
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Diagnosis and Treatment
Canadian institutionsQueen's University
Fundersnot available
KeywordsUrologyMedicine

Abstract

fetched live from OpenAlex

In this issue of the CUAJ, Vigneault et al published their work validating a French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) questionnaire in a French-Canadian population.This represents an important step forward in the quest to incorporate patient-reported outcomes (PRO) into routine clinical practice.There is a multitude of evidence that we, as prostate cancer healthcare providers, underestimate the treatment-related symptom burden of our patients.1 Although, we may frequently minimize this symptom burden in the face of the almighty endpoint of oncological cure, the fact remains that impacts on health-related quality of life are significantly associated with satisfaction with care among both patients and their spouses.2 As such, assessment of a patient's treatment-related symptom burden using a validated questionnaire not only seems intuitive, but has been proposed as a quality indicator in the treatment of early-stage prostate cancer.3 These PROs are not unique to prostate cancer and recently there has been an explosion in the development of PROs for many benign and malignant disease processes within urology; 4 however, routine incorporation of these instruments into the clinic can be problematic.Studies evaluating integration of these instruments into clinical practice have noted that perceived interruptions in clinic efficiency may represent a barrier to widespread adoption.5 Nonetheless, there is objective evidence that systems which maximize the potential of PROs can improve care.Basch et al randomized patients receiving chemotherapy for metastatic cancer to standard of care symptom monitoring or a novel web-based PRO questionnaire platform.If a participant in the PRO group reported a severe or worsening symptom, the clinical nurse responsible for the patient was sent an automated email alert.When compared to the standard of care group, patients in the PRO intervention experienced improved overall survival, improved quality of life, fewer emergency room visits, and a longer time on chemotherapy.6,7 Cancer Care Ontario endorses the use of PROs with the measurable target of having 70% of patients complete these questionnaires."Your Symptoms Matter" kiosks are available at 14 regional cancer centres and 28 partner hospitals across Ontario.A web-based application is also available for patients to use via their home computers (https://isaac.cancercare.on.ca/).Currently, more than 27 000 cancer patients are screened for changes in symptom burden each month through the system.The program originally began using the Edmonton Symptom Assessment Scale (ESAS) to track patient health-related quality of life.Realizing that the ESAS

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.106
metaresearch head score (Gemma)0.242
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.106
Threshold uncertainty score0.562

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1060.242
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0050.010
Science and technology studies0.0020.005
Scholarly communication0.0090.007
Open science0.0040.004
Research integrity0.0030.008
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.263
Teacher spread0.250 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2017
Admission routes3
Has abstractyes

Explore more

Same venueCanadian Urological Association Journal→Same topicProstate Cancer Diagnosis and Treatment→French-language works237,207→